Project/Area Number |
23590647
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Applied pharmacology
|
Research Institution | Dokkyo Medical University |
Principal Investigator |
|
Co-Investigator(Renkei-kenkyūsha) |
ANZAI Naohiko 獨協医科大学, 医学部, 教授 (70276054)
KIMURA Toru 杏林大学, 医学部, 助教 (30433725)
|
Research Collaborator |
WEMPE Michael F. 米国Colorado大学, 薬理学, 教授
TAEJARERNWIRIYAKUL Ormjai 獨協医科大学, 医学部
JAIYEN Chaliya 獨協医科大学, 医学部
|
Project Period (FY) |
2011-04-28 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2013: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | トランスポーター / 尿酸 / 有機酸 / 痛風 / 尿酸降下薬 |
Outline of Final Research Achievements |
Organic anion transporter OAT10 was reported to mediate high-affinitiy nicotinate transport as well as low-affinitiy urate transport. Since I noticed that OAT10 may function as a second apical urate transporter URAT2, here I performed the experiments 1) to clarify the precise mechanisms of urate transport via URAT2 and 2) to accumulate the basic information for the new drug development for urate-lowering agents. As a results, I could find that URAT2 has an exchange mode for intracellular organic anions similar to URAT1 and broader substrate recognition to that of URAT1. In addition, I could get the fundamental structural information to raise novel urate-lowering agents.
|